Antimicrobial therapy for Stenotrophomonas maltophilia infections.
about
Efflux-mediated drug resistance in bacteria: an updateUpdate on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsStenotrophomonas maltophilia: an emerging global opportunistic pathogenAttributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literatureAdhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Clinical characteristics and therapeutic outcomes of nosocomial super-infection in adult bacterial meningitis.Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.Therapy of Infections due to Carbapenem-Resistant Gram-Negative PathogensRisk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulatorMultilocus sequence-based analysis delineates a clonal population of Agrobacterium (Rhizobium) radiobacter (Agrobacterium tumefaciens) of human origin.Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital.Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report.Ventilator Associated Pneumonia in an Infant Caused by Stenotrophomonas maltophila - A Case ReportSurveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?Stenotrophomonas maltophilia: An Emerging Pathogen in Paediatric Population.Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Surveillance and management of multidrug-resistant microorganisms.Current dilemmas in antimicrobial therapy in cystic fibrosis.Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Minimal Inhibitory Concentration of Ceftazidime and Co-trimoxazole for Stenotrophomonas Maltophilia using E-test.A specific polymerase chain reaction method to identify Stenotrophomonas maltophilia.A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia.Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia.Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage.Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study.Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsClinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia.Synergistic interactions in mixed-species biofilms of pathogenic bacteria from the respiratory tract.Isolation of new Stenotrophomonas bacteriophages and genomic characterization of temperate phage S1
P2860
Q24609407-E8E2C790-CC02-4087-B100-5687995D9361Q26782924-92D3A236-C22E-4CE5-A1BF-423D383BDD59Q26995336-F2915AC9-DA16-4969-81C5-C357355D11ACQ28263931-613ECFE2-DAAA-4DB0-B6FD-9E3541EF1CDAQ33550582-BBDA3936-0AC6-4361-9E9C-C91A9D4E9413Q33904780-F5CE4336-DD43-450D-871D-72CD1735AE8BQ33909519-EBE7C0DD-4C7E-43EB-AFD4-04AC3E668963Q34279948-A448D699-209A-463F-BA5F-1BB53951B3F9Q34303970-7960BE0A-9200-4818-8DD8-0149C31E364FQ34466373-3F78708C-9B56-45E5-BBDC-387BA0692C21Q34770892-4B05E9FC-2976-41A2-BF32-D87306731FDCQ35023954-0DC8A202-71A6-4825-A1AC-EEBC3B411F93Q35096148-33F0A1E8-16F8-460B-AD1F-93BC4D7246C2Q35681397-26263CA3-B9FC-461D-993C-4897BBC1A00CQ35767386-C108BFFF-5DB7-4587-93BA-43B0F338E73AQ37055211-B9B63D0F-5378-480B-946C-7A299734333DQ37229067-0BDD39C2-1E76-45D8-B211-68D02CBD3882Q37332941-28D9B905-5B68-47A2-9946-5F0F453609C0Q37352947-3A561CFD-3B6A-4083-992A-BFA02068532BQ37366281-0A5716FD-A5F6-4FA8-BAEA-4E276D01F78DQ37377897-75ABF371-6780-4C57-91EF-98CFDE48B115Q37544504-6B7B5A53-A5EC-4A9E-9346-F023BFD9C001Q37544565-382BBF51-662B-43C6-A2A7-42DA44AAAD13Q37663609-CE61FEFC-A095-4DA1-A86C-178311695E91Q37681071-15D9494D-8175-4EB4-9AD7-13F7B64FCA44Q37866819-8736A3B3-2539-4B1D-82AA-B5636DD23F73Q37912231-79045120-F890-4A9F-ADCE-E41B656B0A37Q38042719-CDD10560-B369-44E8-A7C3-16E786C1BF28Q38188881-ADC0BC66-9EB1-49C8-9E28-D2D479217FFDQ38247296-6419FC1C-EC3C-405E-9856-7FF8C5D01500Q38265741-7094926C-0891-4801-A479-F07E063630D0Q39092623-51BA6AFC-99CF-45C1-A684-C71ADEB0BF03Q40052282-2153461D-A985-4930-8B76-2BBA5B5719B9Q40177415-2F6BD1D4-4244-4DE5-8434-FB65790B43CEQ40285446-BDDCE091-540F-46BE-ACB0-444EB87A4882Q40665545-F4CF6DDA-D1A9-4040-9557-1D9361FD08DCQ40749356-FB513005-6C52-449F-9945-158780E2C45CQ41484669-D028E7FE-0080-48A3-BD9B-031BC0AC6090Q41622958-BA4C7C1C-6056-448D-84E1-61FC20749767Q41789267-979C8CE5-4038-459A-8751-81D231C8AFFD
P2860
Antimicrobial therapy for Stenotrophomonas maltophilia infections.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antimicrobial therapy for Stenotrophomonas maltophilia infections.
@en
type
label
Antimicrobial therapy for Stenotrophomonas maltophilia infections.
@en
prefLabel
Antimicrobial therapy for Stenotrophomonas maltophilia infections.
@en
P2860
P1476
Antimicrobial therapy for Stenotrophomonas maltophilia infections.
@en
P2093
A C Nicodemo
J I Garcia Paez
P2860
P2888
P304
P356
10.1007/S10096-007-0279-3
P577
2007-04-01T00:00:00Z